BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study

BACKGROUND: There is strong evidence regarding the efficacy and effectiveness of the BNT162b2 vaccine in preventing symptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is a relative paucity of data regarding its effectiveness in the prevention of asymptomat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zacay, Galia, Shasha, David, Bareket, Ronen, Kadim, Itai, Hershkowitz Sikron, Fabienne, Tsamir, Judith, Mossinson, David, Heymann, Anthony D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231369/
https://www.ncbi.nlm.nih.gov/pubmed/34189176
http://dx.doi.org/10.1093/ofid/ofab262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231369/
https://www.ncbi.nlm.nih.gov/pubmed/34189176
http://dx.doi.org/10.1093/ofid/ofab262

Ejemplares similares